$54.24
-0.20 (-0.37%)
Abbott Laboratories (ABT)
CAPS Rating:
Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.
RSS Headlines
Fool UK
Recs
Expecting sales and earnings growth to be driven by improving market positions in key growth areas, a better product pipeline (Humira, Kaletra, Tricor, Omnicef, Simdax, vicodin, and Simcor), and increasing demand for the company's innovative medical devices and drugs...Also attractively priced.